MedPath

上海凯宝新谊(新乡)药业有限公司

Ownership
-
Established
1998-07-25
Employees
-
Market Cap
-
Website
www.xinyiyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

151

NMPA:151

Drug Approvals

Doxofylline Tablets

Product Name
多索茶碱片
Approval Number
国药准字H20253537
Approval Date
Mar 4, 2025
NMPA

斑秃丸

Approval Number
国药准字Z41020431
Approval Date
Jul 30, 2024
NMPA

Tiopronin for Injection

Product Name
凯西莱
Approval Number
国药准字H10980086
Approval Date
Jul 30, 2024
NMPA

Tiopronin Enteric-coated Tablets

Product Name
凯西莱
Approval Number
国药准字H41020799
Approval Date
Jul 30, 2024
NMPA

山海丹胶囊

Approval Number
国药准字Z20044444
Approval Date
Jul 30, 2024
NMPA

芪参胶囊

Approval Number
国药准字Z20044445
Approval Date
Jul 30, 2024
NMPA

重感灵片

Approval Number
国药准字Z41022377
Approval Date
Apr 18, 2024
NMPA

Berberine Hydrochloride and Trimethoprim

Product Name
小檗碱甲氧苄啶片
Approval Number
国药准字H41024410
Approval Date
Apr 18, 2024
NMPA

Sodium Tiopronin for Injection

Product Name
注射用硫普罗宁钠
Approval Number
国药准字H20090038
Approval Date
Jul 3, 2023
NMPA

新谊牌元满酒

Approval Number
国食健注G20110341
Approval Date
Nov 11, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.